Oculus Innovative Sciences Inc. (Nasdaq: OCLS) shares are up more than 5 percent on volume of 37,000 shares near the open. The company this morning said OroScience will exclusively market Oculus’ Microcyn-based oral products in the U.S., Canada and European markets. Terms of the revenue-sharing agreement were not disclosed.– Mike Tarsala
Several banking stocks are benefiting early Monday from noted financial bear Meredith Whitney’s bullish comments on the sector. Bank of America (NYSE: BAC) shares are up about 5 percent to $12.50 on premaket volume of 3 million shares, after the analyst said BofA is the cheapest of the banking names, based on her analysis of [...]
JA Solar Holdings Co. (Nasdaq: JASO) shares are up nearly 4 percent to $3.94 on about 10,000 premarket shares traded as of 8:30 a.m. Eastern. The company’s stock was started with a Buy rating and a $5 price target at Needham & Co., saying it is well positioned to benefit from a growing solar market [...]
Cephid (Nasdaq: CPHD) shares are up 9 percent to $9.15 on more than 4,000 premarket shares traded as of 8:30 a.m. Eastern. the molecular-diagnostics company said it has received the FDA’s OK for a new test that the company says can diagnose a bacteria linked to antibiotic-resistant infections, diarrhea and colitis within 45 minutes. – [...]
Rino International (Nasdaq: RINO) shares are up 9 percent to $9.92 on about 7,000 premarket shares traded as of 8:20 a.m. Eastern. The China-based provider of wastewater treatment systems has been granted a Nasdaq Global Markets listing. — Mike Tarsala
SanDisk Corp. (Nasdaq: SNDK) shares are up about 2.5 percent to $14.85 on nearly 10,000 shares traded. Thomas Weisel this morning upgraded the stock to an Overweight from a Market Weight rating.
OSI Pharmaceuticals Inc. (Nasdaq: OSIP) shares are up 9 percent to $31 on premarket volume of about 13,500 shares as of 8:15 Eastern. The company announced new data from its Phase III Saturn study of Tarceva. The drug improved overall survival when used immediately after initial chemotherapy in lung cancer patients. — Mike Tarsala
CardioNet Inc. (Nasdaq: BEAT) shares are down 30 percent to $6.16 on 128,000 premarket shares traded as of 8:15 a.m. Eastern. It is one of the most active stocks in the early premarket. The company this morning announced a reimbursement reduction from one of its key customers, and withdrew its previously stated fiscal 2009 guidance. — [...]